Net profit of Syncom Formulations (India) rose 85.71% to Rs 13.00 crore in the quarter ended December 2024 as against Rs 7.00 crore during the previous quarter ended December 2023. Sales rose 95.78% to Rs 127.53 crore in the quarter ended December 2024 as against Rs 65.14 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 127.53 | 65.14 | 96 |
| OPM % | 11.55 | 11.28 | - |
| PBDT | 18.57 | 10.83 | 71 |
| PBT | 17.26 | 9.38 | 84 |
| NP | 13.00 | 7.00 | 86 |